Universe Pharmaceuticals INCUPC
Price (close)
$4.68
Market cap
$23.5M
P/E
—
Revenue (FY)
$17.9B
Net income
-$3.7B
Dividend yield
—
1-year total return
7.6%
Net margin
-20.6%
Revenue growth
-22.4%
Debt / equity
0.16x
What Universe Pharmaceuticals INC does.
has been widely adopted in China for more than 23 centuries. TCM rests upon the assumption that the human body is an ecosystem, embodying
the fusion of Shen (psyche), Essence (soma), Qi, Moisture (body fluids), and Blood (tissue). Health in the context of TCM is more than
just the absence of diseases, but to identify imbalance in human body and restore harmony. TCM is not only intended to cure diseases but
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $30.7M | $48.0M | $40.1M | $32.3B | $23.0B | $17.9B |
| Net income | $7.6M | $11.3M | -$7.9M | -$6.6B | -$8.7B | -$3.7B |
| Free cash flow | $6.1M | -$2.5M | -$1.4M | $1.1B | -$9.7B | -$5.3B |
More on UPC.
- Universe Pharmaceuticals INC summary
- Universe Pharmaceuticals INC financial statements
- Universe Pharmaceuticals INC key metrics
- Universe Pharmaceuticals INC health scores and style box
- Universe Pharmaceuticals INC earnings
- Universe Pharmaceuticals INC dividends
- Universe Pharmaceuticals INC valuation
- Universe Pharmaceuticals INC ownership and insiders
- Universe Pharmaceuticals INC peers
Figures from Universe Pharmaceuticals INC's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.